Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-10-12

FDA Approved: VIGABATRIN — Supplemental Application (Zydus Pharmaceuticals (USA) Inc.)

View source ↗

Summary

FDA approved a supplemental application for Vigabatrin (VIGABATRIN) submitted by Zydus Pharmaceuticals (USA) Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vigabatrin (Vigabatrin)

Snippet

SUPPL AP for VIGABATRIN (VIGABATRIN)